Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
AMOXICILLIN TRIHYDRATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM , LEVOFLOXACIN, AMOXICILLIN , AZITHROMYCIN, AZITHROMYCIN , IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM., LEVOFLOXACIN
Pari Pharma GmbH
Young Adults and adults with R/R B-cell acute lymphoblastic leukemia (BCP-ALL) or a B cell lymphoma (BCL)
1 trial -
AMOXICILLINE/ACIDE CLAVULANIQUE PANPHARMA 2 g/200 mg ADULTES, poudre pour solution injectable
Pari Pharma GmbH
Intensive care, Ventilator Associated Pneumonia
1 trial -
AMX0035
Amylyx Pharmaceuticals EMEA B.V.
Amyotrophic Lateral Sclerosis
5 trials -
AMX0035, PL1 Oral powder in sachet, oral use
Lacuna Pharma Pty Ltd
Amyotrophic Lateral Sclerosis (ALS)
1 trial -
ANASTROZOLE , PALBOCICLIB , TERSOLISIB, RIBOCICLIB , EXEMESTANE , FULVESTRANT , abemaciclib, TERSOLISIB, TERSOLISIB, TERSOLISIB, LETROZOLE , TERSOLISIB, to match Tersolisib (LY4064809), STX-478
Eli Lilly Co.
Neoplasm Metastasis, Breast Neoplasms
1 trial -
ANHYDROUS DOCETAXEL, FLUOROURACIL, FLUOROURACIL, OXALIPLATIN, CALCIUM LEVOFOLINATE
CERO THERAPEUTICS HOLDINGS, INC.
Locally advanced or metastatic oesogastric adenocarcinoma
1 trial -
APL-2
Lacuna Pharma Pty Ltd
Geographic Atrophy Secondary to Age-Related Macular Degeneration
1 trial -
APL-2, Pegcetacoplan
Apellis Europe B.V.
Geographic Atrophy Secondary to Age-related Macular Degeneration
1 trial -
ARALAST NP 60 mg/kg
Takeda
Chronic Obstructive Pulmonary Disease
1 trial -
ARO-APOC3 PFS
Arrowhead Pharmaceuticals Ireland Limited
Hypertriglyceridemia (HTG)
1 trial -
ARO-APOC3 PFS, ARO-APOC3, 0.9% Normal Saline for injection
Arrowhead Pharmaceuticals Ireland Limited
Familial Chylomicronemia Syndrome (FCS)
1 trial -
ARO-APOC3 PFS, Plozasiran Injection Placebo
Arrowhead Pharmaceuticals Ireland Limited
Severe hypertriglyceridemia (SHTG)
1 trial -
ARO-APOC3 PFS, Plozasiran Injection Placebo
Arrowhead Pharmaceuticals Ireland Limited
Hypertriglyceridemia
1 trial -
ARQ-151 0.3% cream
Arcutis Biotherapeutics
Chronic Plaque Psoriasis
1 trial -
ASCs (Cx401, company code)
Takeda
Anal Fistula
1 trial -
ASP8825
Astellas Pharma Inc
Restless Legs Syndrome
1 trial -
ASP8951, Sodium Chloride 0.9% Intravenous Infusion BP
Astellas Pharma GmbH
Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
1 trial -
ASP8951, Sodium Chloride 0.9% Intravenous Infusion BP
Astellas Pharma GmbH
Claudin (CLDN)18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
1 trial -
ASPRO 320 mg, comprimé, CALCIUM HYDROGEN PHOSPHATE DIHYDRATE, DICLOFENAC ARROW 1 %, gel en flacon pressurisé
Tour Hekla
Thrombotic episodes in superficial venous malformations in children
1 trial -
ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)
Gilead Sciences Pty Limited
Primary Biliary Cholangitis
1 trial -
AT132
Astellas Pharma GmbH
X-linked Myotubular Myopathy (XLMTM)
1 trial -
AT2221
AMICUS THERAPEUTICS PTY LTD
Pompe Disease (Late-onset)
1 trial -
AT2221, ATB200
AMICUS THERAPEUTICS PTY LTD
Adult Subjects With Late Onset Pompe Disease (LOPD)
1 trial -
ATENATIV 50 UI/mL, poudre et solvant pour solution pour perfusion, Atenativ 1000 I.E. - Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung, Atenativ 1000 I.E. Pulver und Lösungsmittel zur Herstellung einer Infusionslösung, Atenativ 1000 UI/20 ml polvere e solvente per soluzione per infusione endovenosa, Atenativ 50 NE/ml por és oldószer oldatos infúzióhoz vagy injekcióhoz, ATENATIV 1000 U.I., polvo y disolvente para solución para perfusión
Lacuna Pharma Pty Ltd
Congenital antithrombin deficiency
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources